C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/1999
10/12/1999	US5965371 Targeting undesired antigens by intracellular expression of antibody capable of binding to the target; delivering a dna sequence with a promoter operably linked to the antibody; expressing antibody and binding antigen in cells of interest
10/12/1999	US5965359 Mixing cells from biological sample with detectable labeled complementary dna probe, detecting the presence of the probe that hybridizes with messenger rna for human platelet-derived growth factor receptor gene
10/12/1999	US5965353 An epitope; for a diagnostic kit
10/12/1999	US5965138 Recombinant chimeric virus and vaccine comprising a long viral genomic region from the herpes virus of turkeys and a short viral genomic region from marek's disease virus; immunizing birds
10/12/1999	US5965136 Bone resorption assay
10/12/1999	US5965134 Immunogenic composition against Classical Swine Fever Virus (CSFV)
10/12/1999	US5965132 Methods and compositions for targeting the vasculature of solid tumors
10/12/1999	US5965129 Purified cathepsin polypeptide and amino acid sequence or immunologically active fragments thereof; administering the novel protein with a pharmaceutical carrier to treat cancer
10/12/1999	US5965125 Hybrid matrix implants and explants
10/12/1999	CA2096851C Tissue plasminogen activator substitution variant
10/12/1999	CA1340781C Tumor specific monoclonal antibodies
10/07/1999	WO1999050436A1 Method of preparing polypeptides in cell-free system and device for its realization
10/07/1999	WO1999050418A1 Treatment and diagnosis of staphylococcal infections
10/07/1999	WO1999050416A1 Tnf-related death ligand
10/07/1999	WO1999050413A2 THERAPEUTIC APPLICATIONS OF MATURE FLINT (mFLINT) POLYPEPTIDES OR OPG3, A MEMBER OF THE TNF RECEPTOR SUPERFAMILY
10/07/1999	WO1999050407A1 Monoclonal antibody against human telomerase catalytic subunit
10/07/1999	WO1999050302A1 Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production
10/07/1999	WO1999050301A2 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue
10/07/1999	WO1999050288A2 Mammalian blood loss-induced gene, kd312
10/07/1999	WO1999050285A2 Production methods and uses of a retrovirus
10/07/1999	WO1999050278A1 Compositions and methods for the identification of lung tumor cells
10/07/1999	WO1999049880A1 Methods for treating an ischemic disorder and improving stroke outcome
10/07/1999	WO1999040197A3 Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
10/07/1999	WO1999031128A3 Human tumor necrosis factor-r2-like proteins
10/07/1999	WO1999029717A3 Postweaning multisystemic wasting syndrome virus from pigs
10/07/1999	DE19814860A1 Bakterielle Transglutaminasen Bacterial transglutaminases
10/07/1999	CA2326588A1 Methods for treating an ischemic disorder and improving stroke outcome
10/07/1999	CA2324517A1 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily
10/07/1999	CA2324441A1 Materials and methods relating to a novel retrovirus
10/07/1999	CA2323833A1 Compositions and methods for the identification of lung tumor cells
10/07/1999	CA2321960A1 Treatment and diagnosis of staphylococcal infections
10/07/1999	CA2321179A1 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue
10/07/1999	CA2291798A1 Monoclonal antibody against human telomerase catalytic subunit
10/06/1999	EP0947583A2 DNA fragments activated in expression of melanoma inhibiting protein (MIA)
10/06/1999	EP0947581A1 Culture medium and use of the same
10/06/1999	EP0947525A1 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue
10/06/1999	EP0946755A1 Methods and compositions for polypeptide engineering
10/06/1999	EP0946740A1 Novel constructs and vectors for the targeted and inducible expression of genes
10/06/1999	EP0946735A1 N-terminally extended proteins expressed in yeast
10/06/1999	EP0946733A1 Hsv/aav hybrid amplicon vectors
10/06/1999	EP0946731A1 Non-m non-o hiv strains, fragments and applications
10/06/1999	EP0946728A1 Bone stimulating factor
10/06/1999	EP0946725A2 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily
10/06/1999	EP0946719A1 Guanine exchange factor of rho gtpase and nucleic acid encoding it
10/06/1999	EP0946711A1 Improved expression vectors
10/06/1999	EP0946199A1 TGF beta 1-RESPONSIVE CELLS FROM BONE MARROW
10/06/1999	EP0779933A4 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
10/06/1999	EP0726951B1 Manufacture and use of polypeptides tagged using binding molecules
10/06/1999	EP0517815B1 AN IgG-1 HUMAN MONOCLONAL ANTIBODY REACTIVE WITH AN HIV-1 GLYCOPROTEIN AND METHOD OF USE
10/06/1999	CN1230993A Expression vectors, cells, and methods for preparing thrombopoietin polypeptides
10/06/1999	CN1230986A Novel host cells and method of producing proteins
10/06/1999	CN1230966A Use of leptin antagonists for treating insulin resistance in type II diabetes
10/06/1999	CN1230549A Escape mutant of surface antigen of hepatitis B virus
10/05/1999	US5962666 Polynucleotide or its complement which codes for enzyme involved in bacterial protein synthesis; for diagnosis and treatment of chlamydia infections such as urogenital disorders and vision defects; bactericides
10/05/1999	US5962664 Psychosis protecting nucleic acid, peptides, compositions and method of use
10/05/1999	US5962653 Methods of obtaining antiviral proteins and antiviral peptides from Nostoc ellipsosporum
10/05/1999	US5962648 Human procollagen or collagen produced in this manner can be made of a single collagen type uncontaminated by other human or non-human collagens.
10/05/1999	US5962411 Human growth hormone variants and methods of administering same
10/05/1999	US5962321 Leukemia inhibitory factor from mammalian species and use thereof to enhance implantation and development of embryos
10/05/1999	US5962316 Cell-cycle regulatory proteins, and uses related thereto
10/05/1999	US5962312 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders
10/05/1999	US5962311 A method of targeting attachment of a short-shafted recombinant adenovirus to a cell so as to effect entry of the short-shafted recombinant adenovirus into the cell.
10/05/1999	US5962303 The invention relates to polynucleotides and polypeptides of bacterial ?topoisomerase iii.?
10/05/1999	US5962295 This invention relates to newly identified polynucleotides and polypeptides, and their production and uses, as well as their variants, agonists and antagonists, and their uses.
10/05/1999	US5962294 Compositions and methods for the identification and synthesis of sialyltransferases
10/05/1999	US5962289 Polysaccharide binding fusion proteins and conjugates
10/05/1999	US5962269 Methods for producing antibodies which specifically bind to interleukin-9 receptor
10/05/1999	US5962267 Proinsulin derivative and process for producing human insulin
10/05/1999	US5962260 Recombinant production of human and bovine receptors for modified low-density lipoprotein
10/05/1999	US5962259 Response regulator polynucleotides
10/05/1999	US5962257 Flea aminopeptidase nucleic acid molecules
10/05/1999	US5962256 Nuclear thyroid hormone receptor-interacting polynucleotides and related molecules and methods
10/05/1999	US5962255 Allowing recombination between vectors coding for polypeptide chains of specific binding pairs (e.g. antibodies); for production of libraries of secreted replicable genetic display packages with antibodies on surface
10/05/1999	US5962253 Mixing peptide having specific carboxy terminus amino acid sequence and flavoprotein, epid, from epidermin synthesis
10/05/1999	US5962252 Assay using marked microbial host cell strains
10/05/1999	US5962240 Mycobacterium proteins and applications
10/05/1999	US5962236 Immunoassay using antibodies against free lysyl pyridinoline cross-links in unhydrolyzed urine sample
10/05/1999	US5962230 Diagnosis and treatment of glaucoma
10/05/1999	CA2074182C Process for the reactivation of denatured protein
10/05/1999	CA1340776C Multispecific antigenic proteins
10/01/1999	CA2249043A1 Novel compounds
09/1999
09/30/1999	WO1999049055A1 Human casb12 polypeptide, a serine protease
09/30/1999	WO1999049045A2 Recombinant major allergen of the pollen of artemisia vulgaris (mugwort)
09/30/1999	WO1999049044A1 Cardiostatin polypeptides and polynucleotides
09/30/1999	WO1999049040A1 HUMAN G-PROTEIN COUPLED RECEPTOR GPR6sb
09/30/1999	WO1999049037A2 Protein phosphatase-related molecules
09/30/1999	WO1999049032A1 Suppressors of cytokine signalling
09/30/1999	WO1999049023A1 The cytokine family member 2-21
09/30/1999	WO1999049020A2 Phenol oxidizing enzyme enzymes
09/30/1999	WO1999049019A2 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics
09/30/1999	WO1999048926A1 ANTIBODY AGAINST HUMAN α1,3-FUCOSE TRANSFERASE Fuc-TVII
09/30/1999	WO1999048921A1 Novel mammalian g-protein coupled receptors having extracellular leucine rich repeat regions
09/30/1999	WO1999048535A1 Formulations for protection of peg-interferon alpha conjugates
09/30/1999	WO1999048521A1 Sciellin and uses thereof
09/30/1999	WO1999048508A1 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms
09/30/1999	WO1999048478A1 Use of glycosaminoglycans degrading enzymes for management of airway associated diseases
09/30/1999	WO1999037788A3 Diagnosis and treatment of aur1 and/or aur2 related disorders
09/30/1999	WO1999035266A3 Human urotensin ii
09/30/1999	WO1999035246A9 Novel steroid-activated nuclear receptors and uses therefor
09/30/1999	WO1998018824A9 Human tumor necrosis factor receptor-like 2

1 ... 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 ... 1125